Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953
1 2 3 4 5

Pla2

phospholipase A2

Pla2; phospholipase A2; GB13351; allergen Api m 1; phosphatidylcholine 2-acylhydrolase; EC 3.1.1.4;

PLA2G10

phospholipase A2, group X

PLA2G10; phospholipase A2, group X; group 10 secretory phospholipase A2; GXPLA2; Group X secretory phospholipase A2; GXSPLA2; Phosphatidylcholine 2 acylhydrolase GX; Phospholipase A2 group X; SPLA2; sPLA2X; sPLA2-X; GX sPLA2; OTTHUMP00000045725; phosphatidylcholine 2-acylhydrolase 10;

PLA2G12A

phospholipase A2, group XIIA

PLA2G12A; phospholipase A2, group XIIA; phospholipase A2, group XII , PLA2G12; group XIIA secretory phospholipase A2; EC 3.1.1.4; Group XIIA secretory phospholipase A2 precursor; GXII sPLA2; Phosphatidylcholine 2 acylhydrolase GXII; Phospholipase A2 group XIIA; PLA2G12; sPLA2-XII; group XII secreted phospholipase A2; group XIIA secreted phospholipase A2; phosphatidylcholine 2-acylhydrolase 12A; GXII; ROSSY;

PLA2G16

phospholipase A2, group XVI

PLA2G16; phospholipase A2, group XVI; HRAS like suppressor 3 , HRASLS3; group XVI phospholipase A2; adipose specific PLA2; AdPLA; H REV107 1; HREV107; HREV107 3; MGC118754.; Adipose specific phospholipase A2; H rev 107 protein homolog; HRAS like suppressor 3; Renal carcinoma antigen NY REN 65; OTTHUMP00000237069; adipose-specific PLA2; HRAS-like suppressor 1; HRAS-like suppressor 3; H-rev 107 protein homolog; Ca-independent phospholipase A1/2; adipose-specific phospholipase A2; renal carcinoma antigen NY-REN-65; HRSL3; HRASLS3; HREV107-1; HREV107-3; H-REV107-1;

PLA2G1B

phospholipase A2, group IB (pancreas)

PLA2G1B; phospholipase A2, group IB (pancreas); PLA2, PLA2A, PPLA2; phospholipase A2; group IB phospholipase A2; phosphatidylcholine 2-acylhydrolase 1B; PLA2; PLA2A; PPLA2; MGC119834; MGC119835;

PLA2G2A

phospholipase A2, group IIA (platelets, synovial fluid)

PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid); phospholipase A2, membrane associated; GIIC sPLA2; enhancing factor; modifier of Min1; group IIA phospholipase A2; secretory group II phospholipase A2; phosphatidylcholine 2-acylhydrolase 2A; non-pancreatic secreted type II phospholipase A2; EF; Mom1; Pla2; sPLA2; sPla2-IIA;

PLA2G2D

phospholipase A2, group IID

PLA2G2D; phospholipase A2, group IID; group IID secretory phospholipase A2; sPLA2S; PLA2IID; sPLA2-IID; GIID sPLA2; secretory phospholipase A2s; phosphatidylcholine 2-acylhydrolase 2D; secretory-type PLA, stroma-associated homolog; SPLASH;

PLA2G2E

phospholipase A2, group IIE

PLA2G2E; phospholipase A2, group IIE; group IIE secretory phospholipase A2; 2IIE; EC 3.1.1.4; GIIE sPLA2; Group IIE secretory phospholipase A2 precursor; Phosphatidylcholine 2 acylhydrolase GIIE; Phosphatidylcholine 2-acylhydrolase 2E; Phospholipase A2 group IIE; sPLA; sPLA2-IIE;

PLA2G4A

phospholipase A2, group IVA (cytosolic, calcium-dependent)

PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent); PLA2G4; cytosolic phospholipase A2; cPLA2 alpha; cPLA2; lysophospholipase; phospholipase A2 group IVA; phosphatidylcholine 2-acylhydrolase; calcium-dependent phospholipid-binding protein; cPLA2-alpha; MGC126350;

PLA2G5

phospholipase A2, group V

PLA2G5; phospholipase A2, group V; calcium-dependent phospholipase A2; Ca2+ dependent phospholipase A2; Calcium dependent phospholipase A2; DKFZp686C2294; Group V phospholipase A2; GV PLA2; gVPLA2; hVPLA(2); MGC46205; OTTHUMP00000044655; PA2G5_HUMAN; Phosphatidylcholine 2 acylhydrolase; Phosphatidylcholine 2-acylhydrolase 5; Phospholipase A2 group V; PLA2 10; PLA2 G5; PLA2-10; sPLA2 Type V; OTTHUMP00000002785; Ca2+-dependent phospholipase A2; GV-PLA2;

PLA2G7

phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)

PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); platelet-activating factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIA-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIA phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2;

PLA2G15

phospholipase A2, group XV

PLA2G15; phospholipase A2, group XV; LYPLA3, lysophospholipase 3 (lysosomal phospholipase A2); group XV phospholipase A2; GXVPLA2; LLPL; 1 O acylceramide synthase; ACS; DKFZp564A0122; LCAT like lysophospholipase; LPLA2; Lysophospholipase 3 (lysosomal phospholipase A2); Lysophospholipase 3; Lysosomal phospholipase A2; OTTHUMP00000174859; UNQ341/PRO540; 1-O-acylceramide synthase; LCAT-like lysophospholipase; LYPLA3;

PLAA

phospholipase A2-activating protein

PLAA; phospholipase A2-activating protein; phospholipase A-2-activating protein; DOA1; DOA1 homolog (S. cerevisiae); FLJ11281; FLJ12699; PLA2P; PLAP; Glycerophosphatase; OTTHUMP00000045176; Phospholipase A 2 activating protein; Phospholipase A2 activating protein; DOA1 homolog; OTTHUMP00000021164; OTTHUMP00000226495;

Pla2g12b

phospholipase A2, group XIIB

GXIIB; FKSG71; PLA2G13; GXIIIsPLA2;

PLA2G4B

phospholipase A2, group IVB (cytosolic)

PLA2G4B; phospholipase A2, group IVB (cytosolic); cytosolic phospholipase A2 beta; cPLA2 beta; HsT16992; DKFZp686N12131; FLJ17693; FLJ42498; FLJ53173; OTTHUMP00000201605; OTTHUMP00000210673; Phospholipase A2 group IVB; cPLA2-beta;

PLA2G6

phospholipase A2, group VI (cytosolic, calcium-independent)

PLA2G6; phospholipase A2, group VI (cytosolic, calcium-independent); 85 kDa calcium-independent phospholipase A2; iPLA2; PARK14; PNPLA9; 85 kDa calcium independent phospholipase A2; CaI PLA2; CaI-PLA2; CaIPLA2; Calcium independent phospholipase A2; Cytosolic calcium independent phospholipase A2; EC 3.1.1.4; Group VI phospholipase A2; GVI; GVI PLA2; INAD1; iPLA(2)beta; IPLA2 VIA; iPLA2beta; NBIA2A; NBIA2B; PA2G6_HUMAN; Patatin like phospholipase domain containing 9; Patatin like phospholipase domain containing protein 9; Phospholipase A2 calcium independent; Phospholipase A2 calcium independent group VI A; Phospholipase A2 group VI; Phospholipase A2 group VI cytosolic calcium independent; PLA2; calcium-independent phospholipase A2; patatin-like phospholipase domain containing 9; cytosolic, calcium-independent phospholipase A2; IPLA2-VIA;

PLA2G2C

phospholipase A2, group IIC

PLA2G2C; phospholipase A2, group IIC; phospholipase A2, group IIC (possible pseudogene); putative inactive group IIC secretory phospholipase A2; Phosphatidylcholine 2-acylhydrolase-like protein GIIC;

PLA2G3

phospholipase A2, group III

PLA2G3; phospholipase A2, group III; group 3 secretory phospholipase A2; GIII SPLA2; sPLA2-III; group III secreted phospholipase A2; group III secretory phospholipase A2; phosphatidylcholine 2-acylhydrolase 3; phosphatidylcholine 2-acylhydrola;

PLA2G4C

phospholipase A2, group IVC (cytosolic, calcium-independent)

PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent); cytosolic phospholipase A2 gamma; cPLA2 gamma; phospholipase A2 group IVC; CPLA2-gamma; FLJ42247; FLJ44164; DKFZp586C0423;

PLA2G4D

phospholipase A2, group IVD (cytosolic)

PLA2G4D; phospholipase A2, group IVD (cytosolic); cytosolic phospholipase A2 delta; cPLA2delta; cPLA2 delta; Phospholipase A2 group IVD; cPLA2-delta; phospholipase A2 delta, cytosolic;

PLA2G4E

phospholipase A2, group IVE

PLA2G4E; phospholipase A2, group IVE; cytosolic phospholipase A2 epsilon; FLJ45651; cPLA2-epsilon; MGC126633; MGC126661;

PLA2G4F

phospholipase A2, group IVF

PLA2G4F; phospholipase A2, group IVF; cytosolic phospholipase A2 zeta; PLA2G4F/Z; cPLA2-zeta; PLA2G4FZ; DKFZp666G192; DKFZp781B229;

PLB1

phospholipase B1

PLB1; phospholipase B1; phospholipase B1, membrane-associated; FLJ30866; PLB; hPLB; Lysophospholipase; Phospholipase A2; Phospholipase B; Phospholipase B/lipase; Phospholipase B1 membrane associated; PLB 1; PLB/LIP;

PLA2R1

phospholipase A2 receptor 1, 180kDa

PLA2R1;phospholipase A2 receptor 1, 180kDa;9042;ENSG00000153246;PLA2R;PLA2-R;PLA2IR;CLEC13C;PLA2G1R;2q23-q24;secretory phospholipase A2 receptor;secretory phospholipase A2 receptor;M-type receptor;C-type lectin domain family 13 member C;180 kDa secretory phospholipase A2 receptor;

RGD1565787

phospholipase A2 inhibitor and LY6/PLAUR domain containing

RGD1565787;

PLA2G2F

phospholipase A2, group IIF

2310033E01Rik

phospholipase A2 inhibitor and LY6/PLAUR domain containing

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends